Alnylam Pharmaceuticals, Inc. · NASDAQ:ALNY

Greenstreet Yvonne received 107 Alnylam Pharmaceuticals, Inc. shares as an award (Form 4)

Traded Sep 19, 2026 · Filed Sep 22, 2026

On Sep 19, 2026, Greenstreet Yvonne (Director, Chief Executive Officer) received 107 Alnylam Pharmaceuticals, Inc. shares as an award, leaving 95,802 shares. Filed Sep 22, 2026 (Form 4).

Awarded
107 shares
Holding after
95,802 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 19, 2026Common StockAward10795,802Direct

Source

View original at SEC

Related